Steve Gavel

Mr Steve Gavel has served as Vice President of Commercial Development since July, 2018. He brings over 28 years of commercial experience in biotech start-ups, leading pharmaceutical and medical device organizations.

Most recently, Mr Gavel worked at Celgene Corporation, where he led US CAR-T commercial development activities for their bb2121 program. In this role, he led commercial launch strategy and execution planning in the United States. Prior to Celgene, Mr Gavel led VELCADE marketing strategy and execution at Takeda Oncology, where he served as Senior Marketing Director.

Prior to Takeda Oncology, Mr Gavel held multiple sales, marketing and market access leadership positions in companies such as Syntex, Immunex, Johnson & Johnson, and IMS Health.

Mr Gavel earned his Bachelor of Science degree in finance and business administration from Millersville University in Millersville, Pennsylvania, USA.